FERRARI, SILVIA MARTINA Statistiche
FERRARI, SILVIA MARTINA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
3,5-diiodo-l-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects.
2011-01-01 Antonelli, Alessandro; Fallahi, P; Ferrari, Sm; Di Domenicantonio, A; Moreno, M; Lanni, A; Goglia, F.
[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders].
2005-01-01 Antonelli, Alessandro; Ferri, C; Fallahi, P; Ferrari, Sm; Ghinoi, A; Mascia, Mt; Ferrannini, Eleuterio
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination
2021-01-01 Patrizio, A.; Ferrari, S. M.; Antonelli, A.; Fallahi, P.
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update
2017-01-01 Fallahi, Poupak; Ferrari, Silvia Martina; Ruffilli, Ilaria; Ragusa, Francesca; Biricotti, Marco; Materazzi, Gabriele; Miccoli, Paolo; Antonelli, Alessandro
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies
2022-01-01 Elia, Giusy; Ferrari, Silvia Martina; Ragusa, Francesca; Paparo, Sabrina Rosaria; Mazzi, Valeria; Ulisse, Salvatore; Benvenga, Salvatore; Antonelli, Alessandro; Fallahi, Poupak
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects.
2005-01-01 Antonelli, Alessandro; Rotondi, M; Fallahi, P; Romagnani, P; Ferrari, Sm; Ferrannini, Eleuterio; Serio, M.
Aggressive thyroid cancer: targeted therapy with sorafenib
2017-01-01 Corrado, A; Ferrari, S. M; Politti, U; Mazzi, V; Miccoli, Mario; Materazzi, Gabriele; Antonelli, Alessandro; Ulisse, S; Fallahi, P; Miccoli, Paolo
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
2008-01-01 Antonelli, Alessandro; Ferri, C; Fallahi, P; Ferrari, Sm; Frascerra, S; Carpi, Angelo; Nicolini, Andrea; Ferrannini, Eleuterio
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro
2014-01-01 Ferrari, Sm; Fallahi, P; La Motta, C; Bocci, G; Corrado, A; Materazzi, G; Galleri, D; Piaggi, S; Danesi, R; Da Settimo, F; Miccoli, P; Antonelli, A
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
2018-01-01 Ferrari, Silvia Martina; La Motta, Concettina; Elia, Giusy; Ragusa, Francesca; Ruffilli, Ilaria; Quattrini, Luca; Paparo, Sabrina Rosaria; Piaggi, Simona; Patrizio, Armando; Ulisse, Salvatore; Baldini, Enke; Materazzi, Gabriele; Fallahi, Poupak; Antonelli, Alessandro
Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
2016-01-01 Ferrari, Silvia Martina; Materazzi, Gabriele; Baldini, Enke; Ulisse, Salvatore; Miccoli, Paolo; Antonelli, Alessandro; Fallahi, Poupak
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy
2015-01-01 Fallahi, Poupak; Ferrari, Silvia; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro
Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity
2020-01-01 Muzzio, M. L.; Kabakian, M. L.; Morosan-Allo, Y.; Ferrari, S.; Fallahi, P.; Fernandez, J.; Santucci, M. P.; Andres-Lacueva, C.; Antonelli, A.; Brenta, G.; Merono, T.
Associations between systemic sclerosis and thyroid diseases
2017-01-01 Fallahi, Poupak; Ruffilli, Ilaria; Giuggioli, Dilia; Colaci, Michele; Ferrari, Silvia Martina; Antonelli, Alessandro; Ferri, Clodoveo
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection
2014-01-01 Fallahi, P; Ferrari, Sm; Politti, U; Giuggioli, D; Ferri, C; Antonelli, Alessandro
Autoimmune endocrine dysfunctions associated with cancer immunotherapies
2019-01-01 Ferrari, S. M.; Fallahi, P.; Elia, G.; Ragusa, F.; Ruffilli, I.; Patrizio, A.; Galdiero, M. R.; Baldini, E.; Ulisse, S.; Marone, G.; Antonelli, A.
Autoimmune thyroid disorders
2015-01-01 Antonelli, Alessandro; Ferrari, Sm; Corrado, A; Di Domenicantonio, A; Fallahi, P.
Both 3,5-diiodo-L-thyronine (T2) and T3 modulate glucose-induced insulin secretion
2017-01-01 Fallahi, Poupak; Ferrari, SILVIA MARTINA; Santini, E.; Camastra, Stefania; Frenzilli, Giada; Puccini, Marco; Goglia, F.; Lanni, A.; Marchetti, Piero; Antonelli, Alessandro
Cabozantinib in Thyroid Cancer
2015-01-01 Fallahi, Poupak; Ferrari, Silvia M; Di Bari, Flavia; Materazzi, Gabriele; Benvenga, Salvatore; Miccoli, Paolo; Antonelli, Alessandro
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer
2018-01-01 Ferrari, Silvia Martina; Elia, Giusy; Piaggi, Simona; Baldini, Enke; Ulisse, Salvatore; Miccoli, Mario; Materazzi, Gabriele; Antonelli, Alessandro; Fallahi, Poupak
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3,5-diiodo-l-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. | 1-gen-2011 | Antonelli, Alessandro; Fallahi, P; Ferrari, Sm; Di Domenicantonio, A; Moreno, M; Lanni, A; Goglia, F. | |
| [Extrahepatic manifestations of hepatitis C virus: the thyroid disorders]. | 1-gen-2005 | Antonelli, Alessandro; Ferri, C; Fallahi, P; Ferrari, Sm; Ghinoi, A; Mascia, Mt; Ferrannini, Eleuterio | |
| A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination | 1-gen-2021 | Patrizio, A.; Ferrari, S. M.; Antonelli, A.; Fallahi, P. | |
| Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update | 1-gen-2017 | Fallahi, Poupak; Ferrari, Silvia Martina; Ruffilli, Ilaria; Ragusa, Francesca; Biricotti, Marco; Materazzi, Gabriele; Miccoli, Paolo; Antonelli, Alessandro | |
| Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies | 1-gen-2022 | Elia, Giusy; Ferrari, Silvia Martina; Ragusa, Francesca; Paparo, Sabrina Rosaria; Mazzi, Valeria; Ulisse, Salvatore; Benvenga, Salvatore; Antonelli, Alessandro; Fallahi, Poupak | |
| Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. | 1-gen-2005 | Antonelli, Alessandro; Rotondi, M; Fallahi, P; Romagnani, P; Ferrari, Sm; Ferrannini, Eleuterio; Serio, M. | |
| Aggressive thyroid cancer: targeted therapy with sorafenib | 1-gen-2017 | Corrado, A; Ferrari, S. M; Politti, U; Mazzi, V; Miccoli, Mario; Materazzi, Gabriele; Antonelli, Alessandro; Ulisse, S; Fallahi, P; Miccoli, Paolo | |
| Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. | 1-gen-2008 | Antonelli, Alessandro; Ferri, C; Fallahi, P; Ferrari, Sm; Frascerra, S; Carpi, Angelo; Nicolini, Andrea; Ferrannini, Eleuterio | |
| Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro | 1-gen-2014 | Ferrari, Sm; Fallahi, P; La Motta, C; Bocci, G; Corrado, A; Materazzi, G; Galleri, D; Piaggi, S; Danesi, R; Da Settimo, F; Miccoli, P; Antonelli, A | |
| Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration | 1-gen-2018 | Ferrari, Silvia Martina; La Motta, Concettina; Elia, Giusy; Ragusa, Francesca; Ruffilli, Ilaria; Quattrini, Luca; Paparo, Sabrina Rosaria; Piaggi, Simona; Patrizio, Armando; Ulisse, Salvatore; Baldini, Enke; Materazzi, Gabriele; Fallahi, Poupak; Antonelli, Alessandro | |
| Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer | 1-gen-2016 | Ferrari, Silvia Martina; Materazzi, Gabriele; Baldini, Enke; Ulisse, Salvatore; Miccoli, Paolo; Antonelli, Alessandro; Fallahi, Poupak | |
| Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy | 1-gen-2015 | Fallahi, Poupak; Ferrari, Silvia; Giuggioli, Dilia; Ferri, Clodoveo; Antonelli, Alessandro | |
| Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity | 1-gen-2020 | Muzzio, M. L.; Kabakian, M. L.; Morosan-Allo, Y.; Ferrari, S.; Fallahi, P.; Fernandez, J.; Santucci, M. P.; Andres-Lacueva, C.; Antonelli, A.; Brenta, G.; Merono, T. | |
| Associations between systemic sclerosis and thyroid diseases | 1-gen-2017 | Fallahi, Poupak; Ruffilli, Ilaria; Giuggioli, Dilia; Colaci, Michele; Ferrari, Silvia Martina; Antonelli, Alessandro; Ferri, Clodoveo | |
| Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection | 1-gen-2014 | Fallahi, P; Ferrari, Sm; Politti, U; Giuggioli, D; Ferri, C; Antonelli, Alessandro | |
| Autoimmune endocrine dysfunctions associated with cancer immunotherapies | 1-gen-2019 | Ferrari, S. M.; Fallahi, P.; Elia, G.; Ragusa, F.; Ruffilli, I.; Patrizio, A.; Galdiero, M. R.; Baldini, E.; Ulisse, S.; Marone, G.; Antonelli, A. | |
| Autoimmune thyroid disorders | 1-gen-2015 | Antonelli, Alessandro; Ferrari, Sm; Corrado, A; Di Domenicantonio, A; Fallahi, P. | |
| Both 3,5-diiodo-L-thyronine (T2) and T3 modulate glucose-induced insulin secretion | 1-gen-2017 | Fallahi, Poupak; Ferrari, SILVIA MARTINA; Santini, E.; Camastra, Stefania; Frenzilli, Giada; Puccini, Marco; Goglia, F.; Lanni, A.; Marchetti, Piero; Antonelli, Alessandro | |
| Cabozantinib in Thyroid Cancer | 1-gen-2015 | Fallahi, Poupak; Ferrari, Silvia M; Di Bari, Flavia; Materazzi, Gabriele; Benvenga, Salvatore; Miccoli, Paolo; Antonelli, Alessandro | |
| CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer | 1-gen-2018 | Ferrari, Silvia Martina; Elia, Giusy; Piaggi, Simona; Baldini, Enke; Ulisse, Salvatore; Miccoli, Mario; Materazzi, Gabriele; Antonelli, Alessandro; Fallahi, Poupak |